ImmunSYS CEO Presents at 2018 NYC Oncology Investor Conference
FORT LAUDERDALE, FL–November 1, 2018–ImmunSYS, Inc. announced today that Chairman & CEO Eamonn Hobbs presented on October 31st at the 2018 NYC Oncology Investor Conference, held at Rockefeller Center in Manhattan. ImmunSYS was one of 31 companies accepted to present to investors attending the conference.
The NYC Oncology Investor Conference 2018 hosted by OneMed Forum, and sponsored by the National Foundation for Cancer Research, the International Cancer Impact Fund, Klosters Innovation Partners, Venable LLP, Torreya Partners, and Marcum is the leading conference for early-stage private and public cancer investing.
Meeting attendees included leading life science and oncology venture capitalists, family offices, lawyers, pharma executives, startup public and private cancer companies, and cancer foundations. The conference provides a forum for discussion of trends, opportunities, and risks in oncology investing, corporate presentations by a select group of public and private oncology companies, and updates on cutting edge science.
For more information on the conference, please visit https://www.nyconcologyconference.com/. In addition, Mr. Hobbs’ presentation from the conference can be viewed below.
ImmunSYS Corporate Presentation